Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+1.58% - - 52.02M
+0.17%+6.27%+0.35%+14.05% 48.95B
-3.91%+15.60%+25.12%+7.11% 40.75B
+3.55%-2.15%+398.96%+603.58% 38.46B
-1.89%-1.55%+7.25%+50.17% 36.38B
+1.47%+5.82%+5.76%+43.52% 28.45B
-1.29%-1.25% - - 16.62B
-2.20%-5.17%+31.23%+126.92% 16.33B
-7.29%-0.52%-6.65%-32.61% 13.65B
-0.47%+3.39%+3.45%+9.24% 13.56B
Average -1.18%+5.79%+58.18%+102.75% 28.13B
Weighted average by Cap. -0.84%+6.92%+73.06%+122.65%
Logo Genkyotex SA.
GenKyoTex SA is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.
Employees
9
  1. Stock Market
  2. Stocks
  3. GKTX Stock